Searched for
CODAGENIX
India’s vaccine development journey: A triumph of the collectiveIn hindsight, the pandemic indeed stretched our endurance to the hilt. Nevertheless, our will to live and save more lives emerged stronger,...- Serum Institute to invest 240 million pounds in UK; leads cross-sector Indian investmentsThe Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software s...
- View: Healthcare will never be the same after Covid – given how fast myths were shattered and consumer behaviours transformedWe outline six common myths that were broken by the pandemic. As we look at the transformations that happened, there is a prescription for ...
- Serum Institute seeks government's intervention over import of Covid vaccine raw material from USIn a letter to commerce secretary Anup Wadhawan and foreign secretary Harsh Vardhan Shringla, director, government and regulatory affairs a...
- Indian pharma industry's Covid-19 vaccine plansSerum Institute of India (SII) - The world's largest vaccine producer will manufacture AstraZeneca Plc's Covishield and another formulation...
- Not without India: World's biggest medicine maker gears up for coronavirus vaccine raceIndia manufactures more than 60% of all vaccines sold across the globe, and while its $40 billion pharmaceutical sector is not yet involved...
- AstraZeneca partner sticks with two full dose regimen in Covid trials in IndiaThe British drugmaker has said its Covid-19 vaccine could be up to 90% effective if administered as a half dose followed by a full dose, bu...
- Bharat Biotech in talks to take COVID-19 vaccine candidate globalThe potential vaccine was found to be safe without any major adverse events in the first two stages of the trials involving about 1,000 peo...
- India's Serum Institute starts manufacturing Codagenix's potential COVID-19 vaccineSerum Institute, the world's largest vaccine maker by the number of doses produced, will develop Codagenix's CDX-005, which is delivered in...
- Serum Institute can supply 400 million doses by December, says CEO Adar PoonawallaPoonawalla said the company plans to make 70 million doses per month and increase this to 100 million. These will be used for phase 3 clini...
- AstraZeneca vaccine's success in early human trials bodes well for Adar PoonawallaAdar Poonawalla's Serum Institute of India is one of Astra Zeneca's partners in the search for the vaccine and will potentially be responsi...
- Seven Indian pharmaceutical companies race to develop vaccine for deadly coronavirusBharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma...
- Serum Institute investing USD 100 million on potential COVID-19 vaccine"Our manufacturing facility is ready and we plan to start production in two months. We are spending more than USD 100 million for this faci...
- Serum Institute, AstraZeneca in talks for vaccine SupplyAstraZeneca also received $1 billion from the US government’s Biomedical Advanced Research and Development Authority (BARDA) for the develo...
- Serum Institute to test if TB vaccine VPM1002 is effective against Covid-19Serum Institute of India, the world’s largest vaccine manufacturer, will soon start clinical trials in the country to test if tuberculosis ...
- Coronavirus vaccine within a year but it won't be 100% effectiveThe vaccine for coronavirus should not be seen as a cure, says Adar Poonawalla of SII.
- Coronavirus vaccine in a year, not 100% cureWe need to be very clear, this is not a 100% solution and cure. Maybe 60-70% of people who take the vaccine will have that protection, the ...
- View: TCS, Infosys, HCL, Nasscom, do you hear the call of COVID19?Once genetic sequencing of a problem bug is carried out, arriving at a probable vaccine is as much a computing and data analytics challenge...
- Serum Institute to be ready with coronavirus vaccine by 2022SII announced that a vaccine candidate for the novel coronavirus, which has killed more than 2,000 people in China since its outbreak in De...
- Novel coronavirus: The hunt for a virus killerSome vaccine candidates for China virus are already at trial stage. But path to pharmacy is strewn with hurdles.
Load More
